Smart wristbands could spot strokes before It's too late

NCT ID NCT07362303

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This trial tests a non-invasive wrist monitor that continuously checks for arm movement asymmetry, a sign of stroke. It aims to alert healthcare workers quickly, reducing delays in treatment. The study involves 1,200 high-risk surgery patients and focuses on device safety and accuracy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Neuralert Monitor (non-invasive wrist-worn device)

What this could lead to

If successful, this device could help hospital staff spot strokes faster in high-risk patients, potentially improving treatment and recovery.

What could go wrong

This is an early-stage trial focused on device accuracy, not patient outcomes. The device may produce false alarms or miss strokes, and results may not apply to all patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hospital of the University of Pennsylvania

    RECRUITING

    Philadelphia, Pennsylvania, 19103, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••